Skip to main navigation Skip to search Skip to main content

A Phase II Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-range Finding Study to Evaluate Safety and Efficacy of ALX-0061 Administered Subcutaneously in Subjects with Moderate to Severe Active Systemic Lupus Erythematosus

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/12/15 → 11/11/17

Funding

  • Ablynx NV: $15,475.00